白血病药物-话题@MedSci - 梅斯（MedSci）

#白血病药物#

19篇内容 | 1061人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2027545, encodeId=2668202e545e2, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, objectType=article, longId=209942, objectId=434e20994255, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=434e20994255, replyNumber=0, likeNumber=94, createdTime=2021-05-20, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=434e20994255, moduleTitle=急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=434e20994255)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027543, encodeId=44b9202e543a2, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, objectType=article, longId=194212, objectId=13c2194212aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13c2194212aa, replyNumber=0, likeNumber=82, createdTime=2021-03-06, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13c2194212aa, moduleTitle=关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=13c2194212aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027544, encodeId=83db202e54499, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=Sci Rep: 白血病药物砒霜显示出治疗小儿脑癌的希望！, objectType=article, longId=198110, objectId=77271981107c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=77271981107c, replyNumber=0, likeNumber=68, createdTime=2021-05-30, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=77271981107c, moduleTitle=Sci Rep: 白血病药物砒霜显示出治疗小儿脑癌的希望！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=77271981107c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027542, encodeId=9fa4202e5421a, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, objectType=article, longId=183900, objectId=823f18390056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=823f18390056, replyNumber=0, likeNumber=82, createdTime=2020-03-30, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=823f18390056, moduleTitle=复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=823f18390056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027541, encodeId=2f08202e541ee, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！, objectType=article, longId=161048, objectId=33fa161048ff, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33fa161048ff, replyNumber=0, likeNumber=75, createdTime=2019-03-23, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33fa161048ff, moduleTitle=Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=33fa161048ff)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027540, encodeId=14ab202e540e5, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=白血病药物的重新使用能够预防黑色素瘤的转移, objectType=article, longId=131450, objectId=49bb1314509c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=49bb1314509c, replyNumber=0, likeNumber=86, createdTime=2018-08-11, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=49bb1314509c, moduleTitle=白血病药物的重新使用能够预防黑色素瘤的转移, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=49bb1314509c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027539, encodeId=a15b202e53900, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=短缺药②｜多因素致白血病药物巯嘌呤停产，有药企已恢复生产, objectType=article, longId=120285, objectId=71ba1202857d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=71ba1202857d, replyNumber=0, likeNumber=74, createdTime=2018-07-31, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=71ba1202857d, moduleTitle=短缺药②｜多因素致白血病药物巯嘌呤停产，有药企已恢复生产, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=71ba1202857d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027538, encodeId=e8f1202e53848, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=NEJM：白血病药物伊马替尼在严重高气道反应性哮喘中的应用, objectType=article, longId=99024, objectId=9226990246c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9226990246c, replyNumber=0, likeNumber=96, createdTime=2017-09-30, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9226990246c, moduleTitle=NEJM：白血病药物伊马替尼在严重高气道反应性哮喘中的应用, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9226990246c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027537, encodeId=620a202e537e6, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期, objectType=article, longId=52073, objectId=0df1520e32c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0df1520e32c, replyNumber=0, likeNumber=63, createdTime=2016-02-26, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0df1520e32c, moduleTitle=诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=0df1520e32c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027536, encodeId=ea7c202e53618, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=失而复得，罗氏白血病药物Gazyvaro重获NICE批准, objectType=article, longId=43573, objectId=74ac435e3f6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=74ac435e3f6, replyNumber=0, likeNumber=56, createdTime=2014-12-24, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=74ac435e3f6, moduleTitle=失而复得，罗氏白血病药物Gazyvaro重获NICE批准, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=74ac435e3f6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027534, encodeId=3741202e53412, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=一三共4.1亿美元收购Ambit获白血病药物quizartinib, objectType=article, longId=40985, objectId=447c409856f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=447c409856f, replyNumber=0, likeNumber=69, createdTime=2015-06-17, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=447c409856f, moduleTitle=一三共4.1亿美元收购Ambit获白血病药物quizartinib, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=447c409856f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027533, encodeId=447d202e533bd, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=诺华因未及时披露白血病药物副作用而道歉, objectType=article, longId=38706, objectId=9a0e38e06f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9a0e38e06f7, replyNumber=0, likeNumber=66, createdTime=2014-10-16, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9a0e38e06f7, moduleTitle=诺华因未及时披露白血病药物副作用而道歉, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=9a0e38e06f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027535, encodeId=478d202e53598, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=Agios白血病药物早期研究结果喜人, objectType=article, longId=42965, objectId=79b44296515, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=79b44296515, replyNumber=0, likeNumber=57, createdTime=2015-09-03, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=79b44296515, moduleTitle=Agios白血病药物早期研究结果喜人, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=79b44296515)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027529, encodeId=585b202e52931, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=John Theurer Cancer发表两项口服白血病药物研究成果, objectType=article, longId=25333, objectId=ddab25333af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ddab25333af, replyNumber=0, likeNumber=72, createdTime=2013-11-06, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ddab25333af, moduleTitle=John Theurer Cancer发表两项口服白血病药物研究成果, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=ddab25333af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027532, encodeId=a2e7202e532f1, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发, objectType=article, longId=27716, objectId=211b2e71647, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=211b2e71647, replyNumber=0, likeNumber=61, createdTime=2014-08-05, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=211b2e71647, moduleTitle=Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=211b2e71647)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027530, encodeId=ae38202e53028, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=杨森向欧盟提交旗下白血病药物Ibrutinib的上市许可申请, objectType=article, longId=26204, objectId=73002620458, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=73002620458, replyNumber=0, likeNumber=75, createdTime=2014-08-07, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=73002620458, moduleTitle=杨森向欧盟提交旗下白血病药物Ibrutinib的上市许可申请, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=73002620458)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027531, encodeId=a26a202e531f1, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售, objectType=article, longId=26205, objectId=fd9b262058c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fd9b262058c, replyNumber=0, likeNumber=71, createdTime=2014-02-18, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fd9b262058c, moduleTitle=FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fd9b262058c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027528, encodeId=f4f2202e528f5, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=GSK着眼于将旗下白血病药物Arzerra打造为一线药物, objectType=article, longId=19870, objectId=adb8198e07a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=adb8198e07a, replyNumber=0, likeNumber=65, createdTime=2013-10-24, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=adb8198e07a, moduleTitle=GSK着眼于将旗下白血病药物Arzerra打造为一线药物, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=adb8198e07a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2027527, encodeId=a23f202e5272a, content=<a href='/topic/show?id=1c14e1796aa' target=_blank style='color:#2F92EE;'>#白血病药物#</a>, objectTitle=Ariad白血病药物ponatinib在PACE试验中取得积极数据, objectType=article, longId=6978, objectId=2dfc69e805, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dfc69e805, replyNumber=0, likeNumber=75, createdTime=2013-05-04, rootId=0, userName=珙桐, userId=25d7319, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dfc69e805, moduleTitle=Ariad白血病药物ponatinib在PACE试验中取得积极数据, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=2dfc69e805)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

白血病药物

2020-05-29

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则

2021-05-20

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

关于公开征求《抗急性淋巴细胞白血病药物临床试验中检测微小残留病的技术指导原则（征求意见稿）》意见的通知

2021-03-06

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

Sci Rep: 白血病药物砒霜显示出治疗小儿脑癌的希望！

2021-05-30

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

复星医药新开发的白血病药物FN-1501获得FDA孤儿药称号

2020-03-30

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

Sci Adv：白血病药物联合PD-1抑制剂增强免疫治疗效果！

2019-03-23

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

白血病药物的重新使用能够预防黑色素瘤的转移

2018-08-11

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

短缺药②｜多因素致白血病药物巯嘌呤停产，有药企已恢复生产

2018-07-31

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

NEJM：白血病药物伊马替尼在严重高气道反应性哮喘中的应用

2017-09-30

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

诺华白血病药物Arzerra III期临床显著改善复发性CLL无进展生存期

2016-02-26

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

失而复得，罗氏白血病药物Gazyvaro重获NICE批准

2014-12-24

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

一三共4.1亿美元收购Ambit获白血病药物quizartinib

2015-06-17

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

诺华因未及时披露白血病药物副作用而道歉

2014-10-16

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

Agios白血病药物早期研究结果喜人

2015-09-03

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

John Theurer Cancer发表两项口服白血病药物研究成果

2013-11-06

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

Cell ：复旦教授破译TET2蛋白三维结构，有望用于白血病药物研发

2014-08-05

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

杨森向欧盟提交旗下白血病药物Ibrutinib的上市许可申请

2014-08-07

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

FDA暂停阿瑞雅德旗下白血病药物Iclusig的销售

2014-02-18

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

GSK着眼于将旗下白血病药物Arzerra打造为一线药物

2013-10-24

珙桐 (审核中...)

前往app查看评论内容

#白血病药物#

Ariad白血病药物ponatinib在PACE试验中取得积极数据

2013-05-04

科室
- - 订阅+
  - 更多科室
工具
服务